Quipt Home Medical Corp. announced its strategic priorities for calendar year 2025, focusing on accelerating organic growth, optimizing capital allocation, and building a scalable healthcare ecosystem through M&A and potential joint ventures. Key initiatives include expanding its De Novo footprint and deepening referral networks.
The company plans to take an aggressive approach to enhancing shareholder value through active share repurchases under its normal course issuer bid. It also intends to adopt a refined M&A strategy, prioritizing alignment with healthcare systems through joint ventures and strategic acquisitions.
At its Annual General Meeting held on March 17, 2025, the four nominated candidates for election to the Board of Directors were successfully elected by a majority of shareholders. BDO USA, P.C. was re-appointed as the company's auditor for the fiscal year ended September 30, 2025.
The Board of Directors also approved the grant of 425,000 stock options and 2,478,753 restricted stock units to eligible officers, directors, employees, and consultants. The options are exercisable at US$2.37 per share and vest over three years, while the restricted stock units vest over two years.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.